Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Risk Factors
100%
Chemotherapy-induced Peripheral Neuropathy
100%
Taxane-based Chemotherapy
100%
Platinum-based Chemotherapy
100%
Neuropathy
45%
Chemotherapy
27%
Symptom Burden
18%
Hong Kong
9%
Inconsistency
9%
Singapore
9%
Infectious Diseases
9%
Diabetes
9%
Quality of Life
9%
Relative Contribution
9%
Old Age
9%
Patient Education
9%
Multivariate Regression Model
9%
Personal Characteristics
9%
Univariate Analysis
9%
Predictor Variables
9%
Cancer Center
9%
Alcohol Use
9%
Treatment Decisions
9%
Prospective Observational Study
9%
Smoking History
9%
Fruit Intake
9%
Key Risk Factors
9%
Potential Risk Factors
9%
Vegetables Fruits
9%
Methodological Limitations
9%
Statins
9%
NCI-CTCAE
9%
Alcohol Intake
9%
History of Chemotherapy
9%
Neurotoxic Chemotherapy
9%
WHO Criteria
9%
WHO Ordinal Scale
9%
Medication History
9%
Difficult to Manage
9%
Chemotherapy Cycles
9%
Sensory-motor
9%
Treatment Characteristics
9%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy-Induced Peripheral Neuropathy
100%
Taxane
100%
Chemotherapy Regimen
100%
Platinum
100%
Neuropathy
36%
Observational Study
9%
Malignant Neoplasm
9%
Prevalence
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Patient History of Chemotherapy
9%
Motor Neuropathy
9%
Diseases
9%
Side Effect
9%
Nursing and Health Professions
Chemotherapy-Induced Peripheral Neuropathy
100%
Chemotherapy
100%
Platinum
100%
Neuropathy
36%
Alcohol Consumption
18%
World Health Organization
18%
Economic and Social Development
18%
Patient Education
9%
Cancer Center
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Motor Neuropathy
9%
Prevalence
9%
Univariate Analysis
9%
Predictor Variable
9%
Patient History of Chemotherapy
9%
Diseases
9%
Quality of Life
9%
Side Effect
9%
Neuroscience
Chemotherapy
100%
Taxane
100%
Neuropathy
100%
Risk Factor
100%
Alcohol Abuse
5%
Statin
5%
Quality of Life
5%
Side Effect
5%